BioCentury
ARTICLE | Financial News

Angion sets IPO terms

May 28, 2014 1:23 AM UTC

Angion Biomedica Corp. (Uniondale, N.Y.) amended its IPO on NASDAQ and now plans to sell 2.7 million shares at $10-$12. At the $11 midpoint, the company would raise $30 million and be valued at $73.1 million. Angion filed to raise up to $34.5 million last month. Aegis Capital is the underwriter. ...